Charles V. Biscotti

No ORCID on file · 5 papers in corpus · active 1989-2013

Study types

  • article 4
  • other 1

Condition tags

  • endometriosis 4
  • chronic_pelvic_pain 1
article 2013
Endometriosis, endometrium, implantation and fallopian tube
·doi:10.1093/humrep/det211

Study question: To compare the pregnancy rate in patients submitted to FET (Frozen Embryos Transfer) of cleavage stage embryos (Group 1), or at the blastocyst stage (Group 2). Summary answer: Our data showed that the transfer of frozen blas…

article 2013
Oxidative Cell Injury as a Predictor of Endometriosis Progression
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719112466301

BackgroundThere is increasing evidence that oxidative stress is one of the key factors for progression of endometriosis. In this prospective controlled trial, we measured 6 different biomarkers of oxidative stress targeting protein, lipid, …

other 2010
Papanicolaou tests associated with cervical mucosal endometriosis: an analysis of cellular features and comparison to endocervical adenocarcinoma in situ
Diagnostic cytopathology ·doi:10.1002/dc.21246

Endometrium directly sampled from endocervical mucosal endometriosis can mimic endocervical adenocarcinoma in situ (AIS) in Papanicolaou (Pap) tests. We analyzed a series of Pap tests to investigate the cellular features of mucosal endometr…

article 2008
Pelvic Endometriosis is Rarely Associated with Ovarian Borderline Tumours, Cytologic and Architectural Atypia: A Clinicopathologic Study
Pathology oncology research : POR ·doi:10.1007/s12253-008-9072-6

Endometriotic foci, especially ovarian ones, with epithelial cytologic atypia may be precursors of cancer. This study presents an overview of the atypical cytological and histopathological findings associated with endometriosis. Six cases o…

article 1989
Ovarian clear cell adenocarcinoma
Gynecologic oncology ·doi:10.1016/0090-8258(89)90637-9

The clinical and pathologic features of 29 cases of ovarian clear cell adenocarcinoma (OCCA) were studied to evaluate outcome and potential predictors of survival. Patients' ages ranged from 30 to 89 years (median, 54 years). The study grou…